Most importantly, the spleen index and pathological H&E staining showed that the side effect of splenomegaly occurred in Nron treatment mice was significantly eliminated in the NCM2 treatment mice (Supplementary Fig. 10). The gene discussed is NRON; the disease is Splenomegaly.